Team:Lethbridge Canada/project
From 2013hs.igem.org
Line 55: | Line 55: | ||
<h1>Contents:</h1> | <h1>Contents:</h1> | ||
- | |||
<ul> | <ul> | ||
<li><a href="#project_intro">Introduction - Why this project?</a></li> | <li><a href="#project_intro">Introduction - Why this project?</a></li> | ||
Line 68: | Line 67: | ||
<li><a href="#project_conclusion">Conclusion</a></li> | <li><a href="#project_conclusion">Conclusion</a></li> | ||
</ul> | </ul> | ||
- | |||
<div id="project_intro"> | <div id="project_intro"> |
Revision as of 20:22, 12 June 2013
Contents:
- Introduction - Why this project?
- What is Oxytocin?
- Parts
- Assays/Promoters - Statistical Results
- Conclusion
Introduction:
Our project, in short, is to create a natural form of oxytocin that can be used for widespread research and medical application. We are creating it in this fashion as opposed to the synthetic form (which has a drastically increased half-life) in the hopes that it will be cheaper and/or more effective for production. A secondary outcome would be to observe if there are any differences in the naturally produced oxytocin versus a synthetically produced oxytocin, in terms of chemical properties or the effects it has on various organisms.
What is Oxytocin?:
Oxytocin itself is a hormone that stimulates contractions during the birth of children and aids the mother in birth. However, oxytocin also has many other applications with social interaction. Oxytocin helps foster a bond between the mother and child, and stimulates a positive reaction when participating in social interaction. However, oxytocin is currently not understood to a vast and comprehensive degree by researchers regarding its effects in certain situations. Oxytocin in some cases provides results suggesting that it will enhance the social behaviours of animals and humans when added to their system; it is thought to improve facial recognition between face-to-face interactions, picking up on emotional cues. The effects of oxytocin could eventually aid people with social bonding disorders like schizophrenia and autism. Yet in some cases, it also produced negative results causing groups to isolate themselves into groups, ignoring any others that are different. Researchers also do not have a strong case towards whether oxytocin will have positive or negative effects in the human body when used long term, as all experiments so far only deal with short term effects on humans. With all of this, having cheap and efficient oxytocin to study could greatly enhance our knowledge of the hormone, and eventually our ability to treat certain social disorders.
Parts:
Oxytocin-Neurophysin1:
We accomplish the task of synthesizing natural oxytocin by creating two separate constructs. Because oxytocin by itself only has a half-life of <10mins a carrier protein is needed in-order to stabilize our hormone for storage. We accomplish this by using Neurophysin I (a carrier molecule) bound to our Oxytocin molecule to create pre-pro oxyphysin, which has a far longer half-life than oxytocin. Once the Oxytocin-Neurophysin I construct is created - effectively stabilizing our hormone – our E. Coli cells can be stored for when production of the hormone is needed. To separate oxytocin from Neurophysin I we use Nec I (aka PCSK1) which cuts in between our oxytocin and Neurophysin molecules to release oxytocin in its functional form.
J23100_B0032_OXT_B0015
NEC1 Enzyme:
As for the cleavage enzyme, Nec I, we constructed multiple promoters in order to find the most efficient way to produce our functional oxytocin when we require it. We will figure this out using our mathematical model where we take into account how many pre-pro oxyphysin will be cut per second per Nec I, how long Nec I lives, etc... Afterwards, we will find the two amounts that correlate best to produce our functional oxytocin without too little or too much cutting enzyme. We have the mathematical model to find out what our projected values are (still in progress) and we have a histidine tag place on our pre-pro oxyphysin so that we can run tests on our constructs.
J231##_B0032_NEC1/PCSK1_B0015
Assays:
dakshfddsjklfhdsjfhksdhfdjkhfgdskhgdjflkghdjlfkghdjkhgkdfghkjfdhgkdfhgjkdfshgklfsdhjgefhlgksdfhgjfdgnjkdfhgiojxdfg
Conclusion:
In the end, we hope to produce a working Oxytocin-Neurophysin I construct along with a functional NEC I construct. If we manage to attain those two constructs, we can obtain the hormone oxytocin in its natural form. It is our hope that our construct will be able to substantially reduce the cost of oxytocin in the commercial environment. Once we have constructed a working system, sending our parts into the parts registry will help future researchers study the effects that oxytocin has on the human system using the naturally occurring form of the hormone.